<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/  dc: http://purl.org/dc/terms/  foaf: http://xmlns.com/foaf/0.1/  og: http://ogp.me/ns#  rdfs: http://www.w3.org/2000/01/rdf-schema#  schema: http://schema.org/  sioc: http://rdfs.org/sioc/ns#  sioct: http://rdfs.org/sioc/types#  skos: http://www.w3.org/2004/02/skos/core#  xsd: http://www.w3.org/2001/XMLSchema# ">
<head>
    <meta charset="utf-8" />
<script>(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","https://www.google-analytics.com/analytics.js","ga");ga("create", "UA-2231938-8", {"cookieDomain":"auto"});ga("require", "linkid", "linkid.js");ga("set", "anonymizeIp", true);ga("send", "pageview");</script>
<meta name="Generator" content="Drupal 8 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Merriweather:300|Lato:italic,700|Josefin+Sans:700,300&amp;subset=latin,latin-ext" media="all" />
<link rel="shortcut icon" href="/core/misc/favicon.ico" type="image/vnd.microsoft.icon" />

        <title>Popular Pages | Insureintell.com</title>
        <link rel="stylesheet" media="all" href="/sites/site.dd/files/css/css_EM7WZGSOXJKTK2E_qJAyBfceGhIB9FIdCRBVbGwvNLg.css" />
<link rel="stylesheet" media="all" href="/sites/site.dd/files/css/css_1g_7Rhof1xPNoR5sXcW2q6l4KX3RXBNPK2sTAkysEdQ.css" />

            
<!--[if lte IE 8]>
<script src="/sites/site.dd/files/js/js_VtafjXmRvoUgAzqzYTA3Wrjkx9wcWhjP0G4ZnnqRamA.js"></script>
<![endif]-->

     <link href='//fonts.googleapis.com/css?family=Raleway:400,300,600' rel='stylesheet' type='text/css'>

                  </head>
<body class="fontyourface path-popular-">
<a href="#main-content" class="visually-hidden focusable skip-link">
    Skip to main content
</a>

  <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
    
<div id="page-wrapper">
    <div id="page">
        <header id="header" class="header" role="banner" aria-label="Site header">
            <div class="section clearfix">
                
                <div class="no-mobile">  <div>
    <div id="block-iiiii-3" class="block block-block-content block-block-content44d5b48e-4a9b-4767-974f-db75c458b064">
    
        
            <div class="content">
            
            <div><table align="center" border="0" cellpadding="1" cellspacing="1" style="width: 60%;">
	<tbody>
		<tr>
			<td style="width: 100%;">
			<h1 class="text-align-center"><a href="/">Insureintell.com</a></h1>

			<p class="text-align-center"><a href="https://www.hannover-re.com"><img alt="" height="30" src="/sites/site.dd/files/2020-06/HannoverRe_0.svg" width="160" /></a>&nbsp; &nbsp;<a href="http://www.rxhistories.com"><img alt="" height="48" src="/sites/site.dd/files/2020-06/Milliman-1_0.svg" width="119" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.scor.com"><img alt="rag" height="43" src="/sites/site.dd/files/2020-06/Logo-SCOR-The-Art-2_0.svg" width="153" /></a>&nbsp;&nbsp;&nbsp;<a href="http://www.rgare.com"><img alt="" height="42" src="/sites/site.dd/files/2020-06/RGA_0.svg" width="117" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.canadalife.com"><img alt="" height="45" src="/sites/site.dd/files/2020-06/CanLife_Blue_0.svg" width="178" /></a></p>

	
			</td>
		</tr>
		<tr>
			<td class="text-align-center" style="width: 100%;">
			<h4><a href="/news">News</a>&nbsp;-&nbsp;<a href="/articles/">Articles</a>&nbsp;-&nbsp;<a href="/newsletter">Newsletter</a>&nbsp;-&nbsp;<a href="/contact">Contact</a>&nbsp;- <a href="/hot-notes">Hot Notes</a></h4>
			</td>
		</tr>
	</tbody>
</table>
</div>
      
        </div>
    </div>

  </div>
</div>
                <nav id="navigation" class="navbar replaceme menu original">
                <div class="menu-header">  <div>
    <div id="block-iiiii-3" class="block block-block-content block-block-content44d5b48e-4a9b-4767-974f-db75c458b064">
    
        
            <div class="content">
            
            <div><table align="center" border="0" cellpadding="1" cellspacing="1" style="width: 60%;">
	<tbody>
		<tr>
			<td style="width: 100%;">
			<h1 class="text-align-center"><a href="/">Insureintell.com</a></h1>

			<p class="text-align-center"><a href="https://www.hannover-re.com"><img alt="" height="30" src="/sites/site.dd/files/2020-06/HannoverRe_0.svg" width="160" /></a>&nbsp; &nbsp;<a href="http://www.rxhistories.com"><img alt="" height="48" src="/sites/site.dd/files/2020-06/Milliman-1_0.svg" width="119" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.scor.com"><img alt="rag" height="43" src="/sites/site.dd/files/2020-06/Logo-SCOR-The-Art-2_0.svg" width="153" /></a>&nbsp;&nbsp;&nbsp;<a href="http://www.rgare.com"><img alt="" height="42" src="/sites/site.dd/files/2020-06/RGA_0.svg" width="117" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.canadalife.com"><img alt="" height="45" src="/sites/site.dd/files/2020-06/CanLife_Blue_0.svg" width="178" /></a></p>

	
			</td>
		</tr>
		<tr>
			<td class="text-align-center" style="width: 100%;">
			<h4><a href="/news">News</a>&nbsp;-&nbsp;<a href="/articles/">Articles</a>&nbsp;-&nbsp;<a href="/newsletter">Newsletter</a>&nbsp;-&nbsp;<a href="/contact">Contact</a>&nbsp;- <a href="/hot-notes">Hot Notes</a></h4>
			</td>
		</tr>
	</tbody>
</table>
</div>
      
        </div>
    </div>

  </div>
 &nbsp; <div id="nav-icon"><span></span><span></span><span></span><span></span><span></span><span></span></div></div>
                    <div class="container">
                    
                    </div>
                </nav>
            </div>
        </header>
                    <div class="highlighted">
                <aside class="section clearfix" role="complementary">
                      <div>
    <div data-drupal-messages-fallback class="hidden"></div>

  </div>

                </aside>
            </div>
                        <div id="main-wrapper" class=" clearfix">
            <div id="main" class="clearfix">
                
                                                    <section class="section">
                        <a id="main-content" tabindex="-1"></a>
                                                                            
                        <div class="ten">
                              <div>
    <div id="block-light-skeleton-page-title--2" class="block block-core block-page-title-block">
    
        
            <div class="content">
            
<div class="sixteen page-title container floated ">
    <h1 class="title_page" >Popular Pages</h2>
</div>


        </div>
    </div>
<section class="page-content container floated ">
<div class="views-element-container"><div class="js-view-dom-id-5f53f62c892a9ed827cd131b4979c0c5aa4bc7d5cb30610593f726200b3986b3">
  
  
  

  
  
  

      <div class="views-row">


<div data-history-node-id="25652" class="node node--type-article node--view-mode-teaser ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/node/25652" hreflang="en">Education For Underwriters: Priority? Luxury? Nuisance?</a>
</h2>
</div>
      
            <div>Fri, 08/01/2008</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div property="schema:text"><blockquote><p><em>“…every dollar spent on training and development per employee results in an increase of $168 in revenue per employee.” </em>
  </p>
<blockquote><p>Jennifer C. Rankin <br />
      LOMA <em>Resource</em> magazine <br />
      June, 2008:16 </p>
</blockquote>
</blockquote>
<p>&nbsp;</p>
<p>The issue of underwriter education has had a renaissance of sorts since the tedious years of the 1990s. Over that interval, this subject was all but anathema, given the priorities and realities of those times. </p>
<p>Not any more. </p>
</div>
      
            <div><h3>
  <a href="/node/25652" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/taxonomy/term/42" property="schema:about" hreflang="en">Underwriting Education</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25653" class="node node--type-article node--view-mode-teaser ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/node/25653" hreflang="en">Type D Personality</a>
</h2>
</div>
      
            <div>Tue, 07/01/2008</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div property="schema:text"><p><strong>Why is this subject important?</strong></p>
<p><em>“Growing evidence indicated that negative emotions may influence the development of CHD.”</em></p>
<blockquote><p>L. D. Kubzansky and I. Kawachi<br />
    Harvard School of Public Health<br />
    <em>Journal of Psychosomatic Research</em><br />
    48(2000):323</p>
</blockquote>
<p><em>“Type D personality was an independent predictor of adverse events in patients optimally treated with the latest </em>[therapies]<em> in interventional cardiology.”</em></p>
<blockquote><p>Susanne S Pedersen, PhD, et al.<br />
    Rotterdam, The Netherlands<br />
    <em>The American Journal of Cardiology</em><br />
    44(2004):997</p>
</blockquote></div>
      
            <div><h3>
  <a href="/node/25653" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/taxonomy/term/27" property="schema:about" hreflang="en">Medical Underwriting</a></div>
              <div><a href="/taxonomy/term/407" property="schema:about" hreflang="en">type d personality</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25654" class="node node--type-article node--view-mode-teaser ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/node/25654" hreflang="en">Debunking The “Control” Myth In Teleunderwriting</a>
</h2>
</div>
      
            <div>Mon, 06/23/2008</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div property="schema:text"><p>At a recent lecture I did for a state underwriting association, a management underwriter for a P&amp;C-based life insurer mentioned her continuing frustrations in trying to convince their sales representatives (once again, I use this as a synonym for agent, broker, intermediary, etc.) to accept teleunderwriting. </p>
<p>In this case…and so many others…the nidus for field resistance was their “concern” for “loss of control” over their clients. </p>
<p>The “control” myth had reared its predictable head once again!</p>
</div>
      
            <div><h3>
  <a href="/node/25654" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/taxonomy/term/34" property="schema:about" hreflang="en">Teleunderwriting</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25655" class="node node--type-article node--view-mode-teaser ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/node/25655" hreflang="en">Cutaneous Lupus Erythematosus</a>
</h2>
</div>
      
            <div>Thu, 05/01/2008</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div property="schema:text"><p><strong>Why is this subject worth reading about?</strong></p>
<p> Most underwriters know a great deal more about SLE (systemic lupus erythematosus) than they do about “skin lupus.”</p>
<p>The intention of this article is to raise awareness of the underwriting issues in the main forms of skin lupus.</p>
</div>
      
            <div><h3>
  <a href="/node/25655" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/taxonomy/term/408" property="schema:about" hreflang="en">cutaneous lupus erythematosus (CLE)</a></div>
              <div><a href="/taxonomy/term/27" property="schema:about" hreflang="en">Medical Underwriting</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25656" class="node node--type-article node--view-mode-teaser ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/node/25656" hreflang="en">Ethyl Glucuronide (EtG): Does it Bring Significant Value as an Underwriting Test?</a>
</h2>
</div>
      
            <div>Tue, 04/01/2008</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div property="schema:text"><p>Alcohol overuse – often but not always identified as “abuse” – and alcohol dependency (alcoholism, a disease) have been insidiously associated with substantial excess mortality – going back to an excellent study by Lincoln National Re in the late 1970s if not before – and well as fulminant excess morbidity. </p>
<p>With the introduction of widespread screening with blood profiles in the mid-1980s, we obtained the results of the gamma-glutamyltransferase (GGT) test on a vast number of insurance applicants. This test has a well-known and profusely-documented association with heavy drinking. In addition, we also had the results of two other tests associated, albeit less strongly so, with alcohol excess, HDL-C and AST (especially when the AST:ALT ratio is significantly elevated). </p></div>
      
            <div><h3>
  <a href="/node/25656" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/taxonomy/term/37" property="schema:about" hreflang="en">alcohol use</a></div>
              <div><a href="/taxonomy/term/409" property="schema:about" hreflang="en">ethyl glucuronide (EtG)</a></div>
              <div><a href="/taxonomy/term/27" property="schema:about" hreflang="en">Medical Underwriting</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25657" class="node node--type-article node--view-mode-teaser ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/node/25657" hreflang="en">Rx Compliance in the Elderly</a>
</h2>
</div>
      
            <div>Sat, 03/01/2008</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div property="schema:text"><p><strong>Why is this subject so important? </strong></p>
<p>Because of the heavy use of pharmaceuticals at ages 65 and over, a phenomenon sometimes described as “polypharmacy.” </p>
</div>
      
            <div><h3>
  <a href="/node/25657" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/taxonomy/term/37" property="schema:about" hreflang="en">alcohol use</a></div>
              <div><a href="/taxonomy/term/27" property="schema:about" hreflang="en">Medical Underwriting</a></div>
              <div><a href="/taxonomy/term/410" property="schema:about" hreflang="en">polypharmacy</a></div>
              <div><a href="/taxonomy/term/267" property="schema:about" hreflang="en">Rx compliance</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25658" class="node node--type-article node--view-mode-teaser ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/node/25658" hreflang="en">Underwriting Serum Ferritin</a>
</h2>
</div>
      
            <div>Fri, 02/01/2008</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div property="schema:text"><p><strong>Why is this subject important? </strong></p>
<p><em>“A high serum ferritin level may serve as a surrogate marker for poor health.” </em></p>
<blockquote><p>Raymond Gambino, MD <br />
    <em>LAB REPORT </em><br />
    17(1995):91 </p>
</blockquote>
<p>We can say the same for an abnormally low serum ferritin, especially in males over 50 and post-menopausal females, doubly so if they are known to have microcytic/Fe-deficiency anemia or GI symptoms. </p>
</div>
      
            <div><h3>
  <a href="/node/25658" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/taxonomy/term/37" property="schema:about" hreflang="en">alcohol use</a></div>
              <div><a href="/taxonomy/term/184" property="schema:about" hreflang="en">cancer (general)</a></div>
              <div><a href="/taxonomy/term/411" property="schema:about" hreflang="en">ferritin</a></div>
              <div><a href="/taxonomy/term/27" property="schema:about" hreflang="en">Medical Underwriting</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25659" class="node node--type-article node--view-mode-teaser ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/node/25659" hreflang="en">Synergy: Seizing the Opportunity Afforded by Teleundewriting to Make Strategic Changes in Your Underwriting Practices</a>
</h2>
</div>
      
            <div>Tue, 01/01/2008</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div property="schema:text"><p> In this final essay in our teleunderwriting series, we will focus on how insurers can capitalize on the introduction of teleunderwriting to make important changes in underwriting practices. It is imperative that insurers use this window of opportunity wisely for two reasons: </p>
<ol>
<li>It is open to you by virtue of the huge positive impact teleunderwriting will have on turnaround time for your sales force. They will be excited about this and other payoffs to them from this new process and you can leverage this to your advantage. </li>
<li>Almost every company in the industry has changes that need to be made regarding requirements and other practices which harmonize with teleunderwriting and/or bring advantages in other ways. Making them invariably means treading lightly. Perhaps less so in this context than at any other point. </li>
</ol>
</div>
      
            <div><h3>
  <a href="/node/25659" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/taxonomy/term/34" property="schema:about" hreflang="en">Teleunderwriting</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25660" class="node node--type-article node--view-mode-teaser ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/node/25660" hreflang="en">Four Birds With One Stone*: Solving Major Producer Issues With Teleunderwriting</a>
</h2>
</div>
      
            <div>Sat, 12/01/2007</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div property="schema:text"><p>Most arguments advanced in support of embracing teleunderwriting have to do with overall corporate and underwriting-specific objectives. </p>
<p>We usually don’t think of teleunderwriting in terms of its broad contribution to assuaging the concerns of those who sell our products (thus, giving us a reason for being on the payroll!). </p>
<p>We should. </p>
<p>This essay is a direct result of a survey report summary, published in the November, 2007 issue of <em>Insurance Marketing</em>. This high-quality monthly circulates widely within the North American agent/broker community.</p></div>
      
            <div><h3>
  <a href="/node/25660" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/taxonomy/term/34" property="schema:about" hreflang="en">Teleunderwriting</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25661" class="node node--type-article node--view-mode-teaser ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/node/25661" hreflang="en">Report of a Brand New Teleunderwriting Survey</a>
</h2>
</div>
      
            <div>Thu, 11/01/2007</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div property="schema:text"><p>We have just completed a survey of 18 American life companies currently engaged in teleunderwriting. The findings should be of interest to all life and health insurers using or considering teleunderwriting. Therefore, this essay will review the results of that survey, with added commentary…as readers have no doubt come to expect from this underwriter! </p>
</div>
      
            <div><h3>
  <a href="/node/25661" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/taxonomy/term/34" property="schema:about" hreflang="en">Teleunderwriting</a></div>
          </div>
  
  </div>

</div>

</div>

      <nav role="navigation" aria-labelledby="pagination-heading--2">
    <h4 id="pagination-heading--2" class="visually-hidden">Pagination</h4>
    <ul class="js-pager__items">
              <li>
          <a href="/popular-/page/94" title="Go to previous page" rel="prev">
            <span class="visually-hidden">Previous page</span>
            <span aria-hidden="true">‹‹</span>
          </a>
        </li>
                    <li>
          Page 95        </li>
                    <li>
          <a href="/popular-/page/96" title="Go to next page" rel="next">
            <span class="visually-hidden">Next page</span>
            <span aria-hidden="true">››</span>
          </a>
        </li>
          </ul>
  </nav>


  
  

  
  
</div>
</div>

</section>



  </div>

                        </div>
                    </section>
                                            </div>
        </div>
        <div class="clearfix"></div>
        <footer class="site-footer">
            <div class="layout-container">
                                                    <div class="site-footer__bottom container page_footer">
                          <div>
    <div id="block-foot-3" class="block block-block-content block-block-content084078bf-6f39-47ba-bdb3-8d97b34316a4">
    
        
            <div class="content">
            
            <div><footer class="text-align-center">
<h5>Insureintell.com is an independent publication designed to provide business information and opinion to life and health insurance underwriters. It is intended to encourage discussion and further research.<br />
Insureintell.com does not recommend any specific action or risk appraisal in any individual life or health insurance application. All information and opinion published should undergo formal scrutiny by underwriting officers, medical directors, actuaries, legal counsel and other insurance professionals as appropriate.</h5>

<h5>Copyright® 2019&nbsp;Hank George, Inc. All Rights Reserved.</h5>
</footer>
</div>
      
        </div>
    </div>

  </div>

                    </div>
                            </div>
        </footer>
    </div>
</div>
  </div>

<div class="region region-page-bottom"><div id="fancy_login_dim_screen"></div><div id="fancy_login_login_box"><div id="fancy_login_form_contents"><a href="#" id="fancy_login_close_button">X</a><div id="fancy_login_user_login_block_wrapper"><form class="fancy-login-user-login-form" data-drupal-selector="fancy-login-user-login-form-2" action="/popular-?page=94" method="post" id="fancy-login-user-login-form--2" accept-charset="UTF-8">
  <div class="js-form-item form-item js-form-type-textfield form-item-name js-form-item-name">
      <label for="edit-name--2" class="js-form-required form-required">Username</label>
        <input autocorrect="none" autocapitalize="none" spellcheck="false" data-drupal-selector="edit-name" type="text" id="edit-name--2" name="name" value="" size="15" maxlength="60" class="form-text required" required="required" aria-required="true" />

        </div>
<div class="js-form-item form-item js-form-type-password form-item-pass js-form-item-pass">
      <label for="edit-pass--2" class="js-form-required form-required">Password</label>
        <input data-drupal-selector="edit-pass" type="password" id="edit-pass--2" name="pass" size="15" maxlength="128" class="form-text required" required="required" aria-required="true" />

        </div>
<input autocomplete="off" data-drupal-selector="form-afc1zffvvckpgjkc5lm3ydrc-yvx9srywx52ncajia0" type="hidden" name="form_build_id" value="form-AFc1ZFFVvcKpgjKc5lm3ydrC-YvX9sRywX52NcaJIA0" />
<input data-drupal-selector="edit-fancy-login-user-login-form-2" type="hidden" name="form_id" value="fancy_login_user_login_form" />
<ul data-drupal-selector="edit-user-links"><li><a href="/user/password" title="Request new password via email.">Request new password</a></li></ul><div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions--2"><input data-drupal-selector="edit-submit-1592923569" type="submit" id="edit-submit-1592923569--2" name="op" value="Log in" class="button js-form-submit form-submit" />
</div>

</form>
</div></div></div></div>
<script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","scriptPath":null,"pathPrefix":"","currentPath":"popular-","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","currentQuery":{"page":"94"}},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"core\/drupal.ajax,core\/html5shiv,core\/jquery.form,ds\/ds_2col_stacked_fluid,extlink\/drupal.extlink,fancy_login\/popup,fontyourface\/font_display_light_skeleton,google_analytics\/google_analytics,light_skeleton\/skeleton,system\/base,views\/views.module","theme":"light_skeleton","theme_token":null},"ajaxTrustedUrl":{"form_action_p_pvdeGsVG5zNF_XLGPTvYSKCf43t8qZYSwcfZl2uzM":true,"\/popular-?page=94\u0026ajax_form=1":true},"fancyLogin":{"screenFadeColor":"grey","screenFadeZIndex":10,"loginBoxBackgroundColor":"white","loginBoxTextColor":"black","loginBoxBorderColor":"black","loginBoxBorderWidth":"1px","loginBoxBorderStyle":"solid","loginPath":"\/user\/login","dimFadeSpeed":null,"boxFadeSpeed":null,"hideObjects":false},"ajax":{"edit-submit-1592923569--2":{"callback":"fancy_login_user_login_block_ajax_callback","event":"mousedown","keypress":true,"prevent":"click","url":"\/popular-?page=94\u0026ajax_form=1","dialogType":"ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Log in"}}},"google_analytics":{"trackOutbound":true,"trackMailto":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"data":{"extlink":{"extTarget":true,"extTargetNoOverride":null,"extNofollow":null,"extFollowNoOverride":null,"extClass":"ext","extLabel":"(link is external)","extImgClass":false,"extSubdomains":true,"extExclude":"","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":false,"extAlertText":"","mailtoClass":"0","mailtoLabel":"(link sends email)"}},"user":{"uid":0,"permissionsHash":"9eefd52671687a581488e58f9810121b71f4049b340084fc527a3c9edd844181"}}</script>
<script src="/sites/site.dd/files/js/js_e6-SH2JCxM0WNYs4R1vHEs5bWDpCzWT3qWBkLw5LK-Q.js"></script>

</body>
</html>
